Clinical trial
Effects of Soy Peptide and Conjugated Linoleic Acid on Body Composition: a Double-blind, Randomized, Placebo-controlled Clinical Trial
NCT04728399 is registered in ClinicalTrials.gov with Fangfang Zeng as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Soy Peptide and Conjugated Linoleic Acid on Body Composition: a Double-blind, Randomized, Placebo-controlled Clinical Trial
- Lead sponsor
- Fangfang Zeng
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 14, 2021
- Completion date
- December 20, 2022
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
overweight or obesity